These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10831533)

  • 1. Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure: a report from the cardiovascular and renal advisory panel of the Food and Drug Administration.
    Grines CL
    Circulation; 2000 May; 101(21):E200-1. PubMed ID: 10831533
    [No Abstract]   [Full Text] [Related]  

  • 2. A Quarter of a Century Later: What is Dofetilide's Clinical Role Today?
    Wolbrette DL; Hussain S; Maraj I; Naccarelli GV
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):3-10. PubMed ID: 29940780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure.
    Torp-Pedersen C; Moller M; Kober L; Camm AJ
    Eur Heart J; 2000 Aug; 21(15):1204-6. PubMed ID: 10924306
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular drugs. Dofetilide.
    Mounsey JP; DiMarco JP
    Circulation; 2000 Nov; 102(21):2665-70. PubMed ID: 11085972
    [No Abstract]   [Full Text] [Related]  

  • 5. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dofetilide for atrial fibrillation.
    Med Lett Drugs Ther; 2000 May; 42(1078):41-2. PubMed ID: 10847114
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
    Lindeboom JE; Kingma JH; Crijns HJ; Dunselman PH
    Am J Cardiol; 2000 Apr; 85(8):1031-3. PubMed ID: 10760352
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
    Singh SN
    Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dofetilide in patients with chronic heart failure and left ventricular dysfunction].
    Latini R
    Ital Heart J Suppl; 2000 Mar; 1(3):427-8. PubMed ID: 10815277
    [No Abstract]   [Full Text] [Related]  

  • 10. Dofetilide for atrial fibrillation.
    Rubin SA
    N Engl J Med; 2000 Jan; 342(4):289-90. PubMed ID: 10660387
    [No Abstract]   [Full Text] [Related]  

  • 11. Dofetilide: a new class III antiarrhythmic agent.
    Roukoz H; Saliba W
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dofetilide: a new drug to control cardiac arrhythmia.
    Elming H; Brendorp B; Pedersen OD; Køber L; Torp-Petersen C
    Expert Opin Pharmacother; 2003 Jun; 4(6):973-85. PubMed ID: 12783593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dofetilide for atrial fibrillation.
    Ferraro P; Khawari A; Boden WE
    N Engl J Med; 2000 Jan; 342(4):289; author reply 290. PubMed ID: 10660386
    [No Abstract]   [Full Text] [Related]  

  • 14. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in heart failure.
    Stevenson WG; Stevenson LW
    N Engl J Med; 1999 Sep; 341(12):910-1. PubMed ID: 10486424
    [No Abstract]   [Full Text] [Related]  

  • 16. Dofetilide. UK 68, UK 68798, Tikosyn, Xelide.
    Drugs R D; 1999 Apr; 1(4):304-11. PubMed ID: 10566050
    [No Abstract]   [Full Text] [Related]  

  • 17. Update of the clinical impact and issues surrounding Dofetilide (Tikosyn) therapy.
    Friedman L; Alexander E
    AACN Adv Crit Care; 2006; 17(2):102-8; quiz 109-110. PubMed ID: 16767008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].
    Vergara G
    Ital Heart J Suppl; 2001 Mar; 2(3):322-3. PubMed ID: 11307794
    [No Abstract]   [Full Text] [Related]  

  • 19. Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation.
    Torp-Pedersen C; Brendorp B; Køber L
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2695-704. PubMed ID: 11060831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
    N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.